134 related articles for article (PubMed ID: 141116)
41. [The selection and surveillance of cadaver kidney recipients. Recent development in graft immunology (author's transl)].
Descamps B
Nouv Presse Med; 1978 Feb; 7(6):457-62. PubMed ID: 345239
[TBL] [Abstract][Full Text] [Related]
42. Biology of transplantation antigens in man; theoretical and practical considerations.
Nehlsen SL; Lalezari P
Vasc Surg; 1974; 8(5):329-36. PubMed ID: 4281978
[No Abstract] [Full Text] [Related]
43. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
[TBL] [Abstract][Full Text] [Related]
44. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
[TBL] [Abstract][Full Text] [Related]
45. The MLR in human cadaveric renal transplantation.
Tait BD; d'Apice AJ; Cove LY
Tissue Antigens; 1978 May; 11(5):399-402. PubMed ID: 151352
[No Abstract] [Full Text] [Related]
46. The clinical significance of pre- and posttransplant immunologic monitoring.
Schmidtke JR; Ferguson RM; Beierle MJ; Simmons RL; Najarian JS
Transplant Proc; 1979 Mar; 11(1):350-3. PubMed ID: 156424
[No Abstract] [Full Text] [Related]
47. A single-center experience with six-antigen-matched kidney transplants.
Washburn WK; Shaffer D; Conway P; Madras PN; Monaco AP
Arch Surg; 1995 Mar; 130(3):277-82. PubMed ID: 7887794
[TBL] [Abstract][Full Text] [Related]
48. The impact of low donor-specific MLR versus HLA-DR compatibility on kidney graft survival.
Langhoff E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
Transplantation; 1985 Jan; 39(1):18-21. PubMed ID: 2578235
[TBL] [Abstract][Full Text] [Related]
49. Mixed-lymphocyte culture response in a related and an unrelated Australian population.
Nanra SK; Boettcher B; Dobson AJ
Med J Aust; 1979 Nov; 2(10):518-21. PubMed ID: 160979
[TBL] [Abstract][Full Text] [Related]
50. Antibodies to donor B lymphocytes and mixed lymphocyte culture blocking in cadaveric renal transplantation.
Ettenger RB; Opelz G; Walker J; Terasaki PI; Uittenbogaart C; Pennisi AJ; Malekzadeh MH; Fine RN
Transplantation; 1978 Apr; 25(4):169-72. PubMed ID: 147530
[TBL] [Abstract][Full Text] [Related]
51. Kidney transplantation, the Halifax experience.
Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
[TBL] [Abstract][Full Text] [Related]
52. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
[TBL] [Abstract][Full Text] [Related]
53. Lymphocyte tissue culture studies on human heart transplant recipients. I. Screening recipients for serum factors which inhibit the mixed lymphocyte reaction.
Coulson AS; MacMillan F; Griepp RB; Stinson EB; Dong E; Shumway NE
Ann Surg; 1974 Jun; 179(6):930-6. PubMed ID: 4275598
[TBL] [Abstract][Full Text] [Related]
54. Donor-specific B and T lymphocyte antibodies and kidney graft survival.
Jeannet M; Benzonana G; Arni I
Transplantation; 1981 Mar; 31(3):160-3. PubMed ID: 7015609
[TBL] [Abstract][Full Text] [Related]
55. The significance of HLA-A and -B matching for cadaver-kidney survival in Stockholm 1970--1976.
Berg B; Collste H; Lundgren G; Magnusson G; Möller E; Ringden O; Groth CG
Scand J Urol Nephrol Suppl; 1977; (42):32-5. PubMed ID: 356218
[TBL] [Abstract][Full Text] [Related]
56. A 14-year experience with kidney transplantation.
Weil R; Schröter GP; West JC; Starzl TE
World J Surg; 1977 Mar; 2(1):145-56. PubMed ID: 141173
[TBL] [Abstract][Full Text] [Related]
57. [The beneficial role of blood transfusion and preganancy in the survival of renal allografts].
Buy-Quang D; Soulillou JP; Fontenaille C; Guimbretière J; Guenel J
Nouv Presse Med; 1977 Nov; 6(38):3503-7. PubMed ID: 341078
[TBL] [Abstract][Full Text] [Related]
58. Donor recipient pairing: an attempt to reconcile its theoretical power with its practical utility.
Bach FH
Clin Nephrol; 1974; 2(1):4-8. PubMed ID: 4150893
[No Abstract] [Full Text] [Related]
59. Mixed lymphocyte culture responses. Lack of correlation with cadaveric renal allograft survival and blood transfusions.
Jeffery JR; Cheung K; Masniuk J; Taylor D
Transplantation; 1984 Jul; 38(1):42-5. PubMed ID: 6234685
[TBL] [Abstract][Full Text] [Related]
60. Dominant effect of histocompatibility on ten-year kidney transplant survival.
Takiff H; Cook DJ; Himaya NS; Mickey MR; Terasaki PI
Transplantation; 1988 Feb; 45(2):410-5. PubMed ID: 3278435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
